128 related articles for article (PubMed ID: 33939839)
1. Nonhomogeneous Markov chain for estimating the cumulative risk of multiple false positive screening tests.
Golmakani MK; Hubbard RA; Miglioretti DL
Biometrics; 2022 Sep; 78(3):1244-1256. PubMed ID: 33939839
[TBL] [Abstract][Full Text] [Related]
2. A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoring.
Hubbard RA; Miglioretti DL
Biometrics; 2013 Mar; 69(1):245-53. PubMed ID: 23383717
[TBL] [Abstract][Full Text] [Related]
3. Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes.
Hubbard RA; Ripping TM; Chubak J; Broeders MJ; Miglioretti DL
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):513-20. PubMed ID: 26721668
[TBL] [Abstract][Full Text] [Related]
4. Modelling the cumulative risk of a false-positive screening test.
Hubbard RA; Miglioretti DL; Smith RA
Stat Methods Med Res; 2010 Oct; 19(5):429-49. PubMed ID: 20356857
[TBL] [Abstract][Full Text] [Related]
5. Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
Braithwaite D; Zhu W; Hubbard RA; O'Meara ES; Miglioretti DL; Geller B; Dittus K; Moore D; Wernli KJ; Mandelblatt J; Kerlikowske K;
J Natl Cancer Inst; 2013 Mar; 105(5):334-41. PubMed ID: 23385442
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
[TBL] [Abstract][Full Text] [Related]
7. Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study.
Hubbard RA; Kerlikowske K; Flowers CI; Yankaskas BC; Zhu W; Miglioretti DL
Ann Intern Med; 2011 Oct; 155(8):481-92. PubMed ID: 22007042
[TBL] [Abstract][Full Text] [Related]
8. Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway.
Tsuruda KM; Larsen M; Román M; Hofvind S
Cancer; 2022 Apr; 128(7):1373-1380. PubMed ID: 34931707
[TBL] [Abstract][Full Text] [Related]
9. Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study.
Singh D; Pitkäniemi J; Malila N; Anttila A
Breast Cancer Res Treat; 2016 Sep; 159(2):305-13. PubMed ID: 27496148
[TBL] [Abstract][Full Text] [Related]
10. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
Schousboe JT; Kerlikowske K; Loh A; Cummings SR
Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cumulative false-positive risk of screening mammography in the United States and Denmark.
Kemp Jacobsen K; Abraham L; Buist DS; Hubbard RA; O'Meara ES; Sprague BL; Kerlikowske K; Vejborg I; Von Euler-Chelpin M; Njor SH
Cancer Epidemiol; 2015 Aug; 39(4):656-63. PubMed ID: 26013768
[TBL] [Abstract][Full Text] [Related]
12. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
13. Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
O'Meara ES; Zhu W; Hubbard RA; Braithwaite D; Kerlikowske K; Dittus KL; Geller B; Wernli KJ; Miglioretti DL
Cancer; 2013 Nov; 119(22):3959-67. PubMed ID: 24037812
[TBL] [Abstract][Full Text] [Related]
14. The cumulative risk of false-positive screening results across screening centres in the Norwegian Breast Cancer Screening Program.
Roman M; Skaane P; Hofvind S
Eur J Radiol; 2014 Sep; 83(9):1639-44. PubMed ID: 24972452
[TBL] [Abstract][Full Text] [Related]
15. Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.
Castells X; Molins E; Macià F
J Epidemiol Community Health; 2006 Apr; 60(4):316-21. PubMed ID: 16537348
[TBL] [Abstract][Full Text] [Related]
16. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
[TBL] [Abstract][Full Text] [Related]
17. Cumulative risks of false positive recall and screen-detected breast cancer after multiple screening examinations.
Kregting LM; van Ravesteyn NT; Chootipongchaivat S; Heijnsdijk EAM; Otten JDM; Broeders MJM; de Koning HJ
Int J Cancer; 2023 Jul; 153(2):312-319. PubMed ID: 37038266
[TBL] [Abstract][Full Text] [Related]
18. Predicting the risk of a false-positive test for women following a mammography screening programme.
Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
[TBL] [Abstract][Full Text] [Related]
19. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
